Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cardiovasc Intervent Radiol. 2012 Jun 22;36(2):449–459. doi: 10.1007/s00270-012-0424-y

Table 7.

Efficacy: response by RECIST/EASL criteria per lesion

Response 1 months after initial DEB-TACE (n = 13 patients) 6 months after initial DEB-TACE (n = 10 patients) 12 months after initial DEB-TACE (n = 6 patients)
No. RECIST (%) No. EASL (%) No. RECIST (%) No. EASL (%) No. RECIST (%) No. EASL (%)
Complete response – – – 1/10 (10) – 2/6 (33)
Partial response – 8/13 (62) 1/10 (10) 3/10 (30) 1/6 (17) 1/6 (17)
Stable disease 13/13 (100) 5/13 (38) 8/10 (80) 6/10 (60) 4/6 (67) 3/6 (50)
Progressive disease – – 1/10 (10) – 1/6 (17) –